100068 17-AAG - CAS 75747-14-7 - Calbiochem

100068
Cenu nelze zjistit
Minimum Quantity needs to be mulitiple of
S dokončenou objednávkou Další informace
Ušetřili jste ()
 
Vyžádat nacenění
Omezená dostupnostOmezená dostupnost
Na skladě 
Přerušeno
Dostupné omezené množství
Dostupnost bude potvrzena
    Remaining : Will advise
      Remaining : Will advise
      Bude poskytnuto
      Kontaktujte Zákaznický servis
      Contact Customer Service
      Zobrazit ceny a dostupnost
      Klikněte pro vytištění této stránky

      Přehled

      Replacement Information

      Tabulka spec. kláve

      Empirical FormulaCAS #
      C₃₁H₄₃N₃O₈ 75747-14-7

      Ceny a dostupnost

      Katalogové čísloDostupnost Balení ks/bal. Cena Množství
      100068-500UG
      Zjišťuji dostupnost...
      Omezená dostupnostOmezená dostupnost
      Na skladě 
      Přerušeno
      Dostupné omezené množství
      Dostupnost bude potvrzena
        Remaining : Will advise
          Remaining : Will advise
          Bude poskytnuto
          Kontaktujte Zákaznický servis
          Contact Customer Service

          Plastová ampulka 500 μg
          Zjišťuji cenu...
          Cenu nelze zjistit
          Minimum Quantity needs to be mulitiple of
          S dokončenou objednávkou Další informace
          Ušetřili jste ()
           
          Vyžádat nacenění
          Description
          OverviewA less toxic, potent, synthetic derivative of the ansamycin benzoquinone antibiotic Geldanamycin, Streptomyces hygroscopicus (Cat. No. 345805) that binds to Hsp90 (EC50 = 7.2 µM) and regulates its function. Induces apoptosis and displays antitumor effects (IC50 = 4.1 nM in SKBR3 and 5.2 nM in MCF7 cells). Depletes cancer cells of erbB-1, erbB-2 (EC50 = 45 nM), mutant p53 (EC50 = 62 nM), Raf-1 (EC50 = 80 nM), and Akt and hence inhibits the Ras/Raf/MEK and PI3-kinase signaling pathways. Also sensitizes cancer cells to Paclitaxel (Cat. No. 580555) and Doxorubicin (Cat. No. 324380) and downregulates vascular endothelial growth factor expression.
          Catalogue Number100068
          Brand Family Calbiochem®
          SynonymsNSC-330507, 17-AG, 17-(Allylamino)-17-demethoxygeldanamycin, 17-Allylaminogeldanamycin
          References
          ReferencesBasso, A.D., et al. 2002. Oncogene 21, 1159.
          Clarke, P.A., et al. 2002. Oncogene 19, 4125.
          Clarke, P.A., et al. 2000. Oncogene 19, 4125.
          Schulte, T.W., and Neckers, L.M. 1998. Cancer Chemother. Pharmacol. 42, 273.
          Schnur, R.C., et al. 1995. J. Med. Chem. 38, 3806.
          Product Information
          CAS number75747-14-7
          ATP CompetitiveN
          FormPurple solid
          Hill FormulaC₃₁H₄₃N₃O₈
          Chemical formulaC₃₁H₄₃N₃O₈
          ReversibleN
          Structure formula ImageStructure formula Image
          Applications
          Biological Information
          Primary TargetHsp90
          Primary Target IC<sub>50</sub>EC50 = 7.2 µM for Hsp90
          Purity≥98% by HPLC
          Physicochemical Information
          Cell permeableN
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Blue Ice Only
          Toxicity Standard Handling
          Storage -20°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          MSDS

          Title

          Safety Data Sheet (SDS) 

          Certificates of Analysis

          TitleLot Number
          100068

          References

          Přehled odkazů
          Basso, A.D., et al. 2002. Oncogene 21, 1159.
          Clarke, P.A., et al. 2002. Oncogene 19, 4125.
          Clarke, P.A., et al. 2000. Oncogene 19, 4125.
          Schulte, T.W., and Neckers, L.M. 1998. Cancer Chemother. Pharmacol. 42, 273.
          Schnur, R.C., et al. 1995. J. Med. Chem. 38, 3806.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision03-October-2007 RFH
          SynonymsNSC-330507, 17-AG, 17-(Allylamino)-17-demethoxygeldanamycin, 17-Allylaminogeldanamycin
          DescriptionA less toxic, potent, synthetic derivative of the ansamycin benzoquinone antibiotic Geldanamycin Streptomyces hygroscopicus (Cat. No. 345805) that binds to Hsp90 (EC50 = 7.2 µM) and regulates its function. Reported to induce apoptosis and exhibit anti-tumor properties (IC50 = 4.1 nM in SKBR3 and 5.2 nM in MCF7 cells). Depletes cancer cells of erbB-1, erbB-2 (EC50 = 45 nM), mutant p53, (EC50 = 62 nM), Raf-1 (EC50 = 80 nM), and Akt. Hence, inhibits the Ras/Raf/MEK and PI3-Kinase signaling pathways. Shown to sensitize cancer cells to Paclitaxel (Cat. No. 580555) and Doxorubicin (Cat. No. 324380), and down-regulates vascular endothelial factor expression.
          FormPurple solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number75747-14-7
          Chemical formulaC₃₁H₄₃N₃O₈
          Structure formulaStructure formula
          Purity≥98% by HPLC
          SolubilityDMSO (10 mg/ml) or Methanol (10 mg/ml)
          Storage -20°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Standard Handling
          ReferencesBasso, A.D., et al. 2002. Oncogene 21, 1159.
          Clarke, P.A., et al. 2002. Oncogene 19, 4125.
          Clarke, P.A., et al. 2000. Oncogene 19, 4125.
          Schulte, T.W., and Neckers, L.M. 1998. Cancer Chemother. Pharmacol. 42, 273.
          Schnur, R.C., et al. 1995. J. Med. Chem. 38, 3806.

          Související produkty a aplikace

          Accessories (Primary)

          Katalogové číslo Popis  
          100070 Selektivní agar (základ) bez krve pro Campylobacter (modifikace CCDA) Zobrazit ceny a dostupnost
          100079 Boltonův selektivní bujón Zobrazit ceny a dostupnost
          104143 Singlepath® Campylobacter Zobrazit ceny a dostupnost

          Accessories (Secondary)

          Katalogové číslo Popis  
          100079 Boltonův selektivní bujón Zobrazit ceny a dostupnost
          104143 Singlepath® Campylobacter Zobrazit ceny a dostupnost

          Kategorie

          Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Other Inhibitors of Biological Interest > Heat Shock Protein Inhibitors